Reply to the letter by Ferraro and Biganzoli
BJU Int
.
2022 Mar;129(3):419.
doi: 10.1111/bju.15642.
Authors
Per-Olof Lundgren
1
,
Anders Kjellman
1
,
Ulf Norming
2
,
Ove Gustafsson
1
Affiliations
1
Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
2
Department of Clinical Science and Education, Karolinska Institutet and Södersjukhuset, Stockholm, Sweden.
PMID:
35297161
DOI:
10.1111/bju.15642
No abstract available
Publication types
Letter
Comment